New eye injection aims to cut treatment visits in half for blinding disease
NCT ID NCT06795048
Summary
This study is testing if a medication called faricimab, given as an injection into the eye, can effectively control 'wet' age-related macular degeneration (AMD) while allowing for less frequent treatments. It involves about 274 people who have not yet received treatment for this condition in their study eye. The main goal is to see if the treatment can be safely given as infrequently as every 24 weeks while still preserving vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adelaide Eye and Retina Centre
Adelaide, South Australia, 5000, Australia
-
Asan Medical Center
Seoul, 05505, South Korea
-
Augenzentrum Prof. Koch GmbH
Frankfurt, 60549, Germany
-
Augenzentrum am St Franziskus-Hospital
Münster, Germany
-
Azienda Ospedaliera Universitaria "Luigi Vanvitelli";UOC Oculistica
Napoli, Sicily, 80138, Italy
-
Azienda Ospedaliero Universitaria Ospedali Riuniti
Torrette - Ancona, The Marches, 60126, Italy
-
Azienda ospedaliero - universitaria Sant'Andrea;UOC Oculistica
Rome, Lazio, 00189, Italy
-
Azienda ospedaliero universitaria Policlinico Riuniti di Foggia;SC Oculistica
Foggia, Apulia, 71122, Italy
-
Cardiff and Vale University Health Board
Cardiff, CF14 4XW, United Kingdom
-
Centre For Eye Research Australia
East Melbourne, Victoria, 3002, Australia
-
Centre Ophtalmologique de L'Odeon
Paris, 75006, France
-
Centre Retine Gallien
Bordeaux, 33000, France
-
Centres Ophtalmologique St Exupéry
Saint-Cyr-sur-Loire, 37540, France
-
Charles Retina Institute
Germantown, Tennessee, 38138, United States
-
China Medical University Hospital
Taichung, 404332, Taiwan
-
Clinica Baviera
Madrid, 28046, Spain
-
Clinique de l'Union
Saint-Jean, 31240, France
-
Ctr for Retina & Macular Dis
Winter Haven, Florida, 33880, United States
-
Eye and ENT hospital, Fudan University
Shanghai, China
-
Florida Retina Institute
Orlando, Florida, 32806-1101, United States
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, 20122, Italy
-
Hopital Edouard Herriot - CHU Lyon
Lyon, 69437, France
-
Hopital Lariboisiere
Paris, 75010, France
-
Hopital du Saint Sacrement
Québec, Quebec, G1S 4L8, Canada
-
Hospital General de Catalunya
Sant Cugat de Valles, Barcelona, 08190, Spain
-
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
-
Liverpool University Hospitals NHS Foundation Trust
Liverpool, L7 8XP, United Kingdom
-
Medizinische Hochschule Hannover, Klinik für Augenheilkunde
Hanover, 30625, Germany
-
Moorfields Eye Hospital NHS Foundation Trust
London, EC1V 2PD, United Kingdom
-
National Taiwan University Hospital
Zhongzheng Dist., 10002, Taiwan
-
New Cross Hospital
Wolverhampton, WV10 0QP, United Kingdom
-
New England Retina Consultants
Springfield, Massachusetts, 01107, United States
-
NewcastleUniversity& The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, NE1 4LP, United Kingdom
-
Oftalvist
Burjassot, Valencia(España), Valencia, 46100, Spain
-
Orange County Retina Medical Group
Santa Ana, California, 92705, United States
-
Ospedale San Giuseppe
Milan, Lombardy, 20123, Italy
-
Peking University People's Hospital
Beijing, 100044, China
-
Pusan National University Hospital
Busan, 49241, South Korea
-
Retina Associates of New Jersey
Teaneck, New Jersey, 07666, United States
-
Retina Consultants of Texas
Schertz, Texas, 78154, United States
-
Retina Institute of Ottawa
Ottawa, Ontario, K2B 7E9, Canada
-
Retina Specialists Victoria
Rowville, Victoria, 3178, Australia
-
Retinal Vitreal Consultants
Chicago, Illinois, 60616, United States
-
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Sichuan Provincial People's Hospital
Chengdu, 610072, China
-
Sierra Eye Associates
Sparks, Nevada, 89434, United States
-
Singapore Eye Research Institute
Singapore, 168751, Singapore
-
St James University Hospital
Leeds, LS9 7TF, United Kingdom
-
St. Joseph's Health Care
London, Ontario, N6A 4V2, Canada
-
Strathfield Retina Clinic
Strathfield, New South Wales, 2135, Australia
-
Sydney Eye Hospital
Sydney, New South Wales, 2000, Australia
-
Tan Tock Seng Hospital
Singapore, 308433, Singapore
-
The Lions Eye Institute
Nedlands, Western Australia, 6009, Australia
-
Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech
Wuhan, 430030, China
-
Toronto Retina Institute
Toronto, Ontario, M3C 0G9, Canada
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
-
Universitatsklinikum Ulm, Augenklinik und Poliklinik
Ulm, 89075, Germany
-
University Retina and Macula Associates, PC
Lemont, Illinois, 60439, United States
-
Universitätsklinikum Würzburg, Augenklinik und Poliklinik
Würzburg, 97080, Germany
-
Vision Research Center at Eye Associates of New Mexico
Albuquerque, New Mexico, 87109, United States
-
West China Hospital of Sichuan University
Chengdu, 610041, China
-
Yeungnam Univ. Hospital
Daegu, 42415, South Korea
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, 510060, China
Conditions
Explore the condition pages connected to this study.